Geneoscopy Closes $105M in Series B Funding - FinSMEs

Nov 17, 2021 · Geneoscopy, a ST Louis, MO-based life sciences company focused on development of diagnostic tests for gastrointestinal health, raised $105M in Series B funding.. …

CouponFollow Extension

$105
OFF

Geneoscopy Closes $105M In Series B Funding - FinSMEs

6 days from now

Nov 17, 2021 · Geneoscopy, a ST Louis, MO-based life sciences company focused on development of diagnostic tests for gastrointestinal health, raised $105M in Series B funding.. …

finsmes.com

$105
OFF

Geneoscopy Closes $105M In Financing To Advance Its …

6 days from now

Nov 16, 2021 · Funding to support U.S. CRC-PREVENT pivotal trial, scale commercial infrastructure, and expand diagnostic product pipeline. ST. LOUIS, Nov. 16, 2021 …

geneoscopy.com

$105
OFF

Geneoscopy Closes $105M Series B Financing Round - GenomeWeb

6 days from now

Nov 16, 2021 · NEW YORK – Gastrointestinal health diagnostics company Geneoscopy said on Tuesday that it has closed a Series B financing round, raising $105 million through a …

genomeweb.com

$105000000
OFF

Series B - Geneoscopy - 2021-11-16 - Crunchbase Funding Round …

6 days from now

Nov 16, 2021 · Geneoscopy raised $105000000 on 2021-11-16 in Series B. Search Crunchbase. Start Free Trial ... Edit Overview Section. Organization Name . Geneoscopy . Announced Date …

crunchbase.com

$105
OFF

Geneoscopy Closes $105M In Financing To Advance Its …

6 days from now

Nov 16, 2021 · Geneoscopy Closes $105M in Financing to Advance its Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention November 16 2021 - 08:01AM PR …

advfn.com

$105
OFF

Geneoscopy Closes $105M In Financing To Advance Its …

6 days from now

On November 16, 2021 Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, reported the closing of a Series B financing, raising …

1stoncology.com

$105
OFF

Funding To Support U.S. CRC-PREVENT Pivotal Trial, Scale …

6 days from now

Geneoscopy Closes $105M in Financing to Advance its Noninvasive ... Funding to support U.S. CRC-PREVENT pivotal trial, scale commercial infrastructure, and expand diagnostic product …

squarespace.com

$6
OFF

Geneoscopy Raises $6.9M In Series A Funding - FinSMEs

6 days from now

Oct 2, 2019 · Geneoscopy, Inc., a St. Louis-based life sciences company focused on the development of diagnostic tests for gastrointestinal (GI) health, raised $6.9m in Series A …

finsmes.com

$105
OFF

BioGenerator Company Geneoscopy Closes $105M Financing To …

6 days from now

Funding to support U.S. CRC-PREVENT pivotal trial, scale commercial infrastructure, and expand diagnostic product pipeline ST. LOUIS, Nov. 16, 2021 /PRNewswire/ -- Geneoscopy Inc., a life …

biogeneratorventures.com

$105
OFF

Geneoscopy Closes $105M In Financing To Advance Its ... - BioSpace

6 days from now

Nov 16, 2021 · Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the closing of a Series B …

biospace.com

$105
OFF

Geneoscopy Closes $105M In Financing To Advance Its …

6 days from now

Geneoscopy Closes $105M in Financing to Advance its Noninvasive Multifactor RNA Screening Test for Colorectal Cancer Prevention

advfn.com

$7
OFF

Marani Health Raises $7.6M In Seed Funding - Finsmes.com

6 days from now

Nov 17, 2021 · FinSMEs The Website About Venture Capital News . ... Geneoscopy Closes $105M in Series B Funding. Next article. The Luupe Raises $3M in Seed Funding. RELATED …

finsmes.com

$105
OFF

Pathalys Pharma Raises $105M In Series B Funding - FinSMEs

6 days from now

Aug 20, 2024 · Pathalys Pharma, a Research Triangle Park, NC-based private biopharmaceutical company in the late stages of developing treatments for kidney disease, raised $105M in …

finsmes.com

$43
OFF

Ribbon Health Raises $43.5M In Series B Funding - FinSMEs

6 days from now

Nov 17, 2021 · Ribbon Health, a New York-based API data platform for the healthcare industry, raised $43.5M in Series B funding.. The round was led by General Catalyst and with …

finsmes.com

FAQs about Geneoscopy Closes $105M in Series B Funding - FinSMEs Coupon?

What happened to geneoscopy?

ST. LOUIS, Nov. 16, 2021 /PRNewswire/ -- Geneoscopy Inc., a life sciences company focused on the development of diagnostic tests for gastrointestinal health, today announced the closing of a Series B financing, raising a total of $105 million through a combination of debt and equity. ...

What does geneoscopy do?

Geneoscopy Inc. is a life sciences company focused on the development of diagnostic tests for gastrointestinal health. Geneoscopy's lead diagnostic uses stool-derived eukaryotic RNA (seRNA) to detect colorectal cancer and precancerous adenomas. ...

Is geneoscopy a breakthrough device?

Early detection is critical as it allows these lesions to be removed and prevents progression to cancer. The U.S. Food and Drug Administration (FDA) granted Geneoscopy's test its Breakthrough Device Designation in January 2020. ...